Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune Sea 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 22 of 37
Health
Iceland wants Pfizer to conduct a nationwide COVID-19 study. There’s just one problem: it has too few cases.
By
Kristen V. Brown
,
Ragnhildur Sigurdardottir
and
Bloomberg
February 15, 2021
Health
How each U.S. state is doing when it comes to COVID vaccine distribution
By
Erika Fry
and
Nicolas Rapp
February 11, 2021
Health
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
By
Riley Griffin
and
Bloomberg
February 10, 2021
Health
J&J’s COVID vaccine could make its global debut as soon as next week
By
David Meyer
February 10, 2021
Health
The AstraZeneca COVID-19 vaccine (and possibly others) are ineffective against the South African variant
By
Jeremy Kahn
February 8, 2021
Health
How to stop vaccine nationalism from prolonging the pandemic
By
David Meyer
February 7, 2021
Health
University of Oxford finds AstraZeneca vaccine effective on British variant
By
Eric Pfanner
,
James Paton
and
Bloomberg
February 5, 2021
Leadership
What happened at Fortune’s not-in-Davos gathering of business leaders
By
Fortune Editors
February 3, 2021
Health
The AstraZeneca vaccine cuts COVID transmission—and delaying the second dose is a good idea, study finds
By
Jeremy Kahn
February 3, 2021
Magazine
Pfizer’s CEO thinks a vaccine-resistant COVID variant is ‘likely’—but that’s not as scary as it sounds
By
Clifton Leaf
February 3, 2021
Health
Why Europe’s summer COVID vaccination target could still be on track
By
David Meyer
February 1, 2021
Health
With supplies running low, Europe approves AstraZeneca’s COVID-19 vaccine for all adults
By
Jeremy Kahn
and
David Meyer
January 29, 2021
Leadership
Pfizer is investing in a ‘surveillance network’ to detect coronavirus variants
By
Beth Kowitt
January 29, 2021
Health
Biden Administration pledges to order additional 200 million doses and speed up pace of vaccinations
By
Josh Wingrove
,
Mario Parker
and
Bloomberg
January 27, 2021
Health
What to know about delaying second COVID vaccine shots as countries grapple with limited supplies
By
John Lauerman
,
Jason Gale
and
Bloomberg
January 26, 2021
Most Popular
Innovation
Rivian's CFO hints the end of EV tax credits means manufacturers are being forced to finally make more affordable...
By
Jordyn Grzelewski
and
Tech Brew
Success
CEO of $62 billion software giant Workday's warning: 'There's nothing more dangerous than yesterday's success'
By
Emma Burleigh
Success
Walmart CEO said paying its star managers upwards of $620,000 yearly empowered them to ‘feel like owners’
By
Emma Burleigh